HK Stock MarketDetailed Quotes
06821 ASYMCHEM
- 53.200
- 0.0000.00%
Pre-Opening Auction Nov 25 09:00 CST
19.56BMarket Cap22.94P/E (TTM)
0.000High0.000Low0Volume0.000Open53.200Pre Close0.00Turnover0.00%Turnover Ratio7.81P/E (Static)367.72MShares101.62352wk High1.06P/B1.47BFloat Cap37.60052wk Low1.99Dividend TTM27.55MShs Float272.513Historical High1.986Dividend LFY0.00%Amplitude37.600Historical Low--Avg Price100Lot Size3.73%Div YieldTTM3.73%Div Yield LFY
ASYMCHEM Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -35.52%4.09B | -42.23%2.66B | -39.29%1.36B | -23.94%7.78B | -18.64%6.34B | -8.71%4.6B | 9.04%2.25B | 120.85%10.23B | 166.80%7.8B | 186.75%5.03B |
| Operating income | -35.52%4.09B | -42.23%2.66B | -39.29%1.36B | -23.94%7.78B | -18.64%6.34B | -8.71%4.6B | 9.04%2.25B | 120.85%10.23B | 166.80%7.8B | 186.75%5.03B |
| Cost of sales | 20.26%-2.33B | 28.06%-1.56B | 31.87%-790.6M | 29.19%-3.82B | 29.38%-2.93B | 18.79%-2.17B | -2.79%-1.16B | -109.02%-5.4B | ---4.15B | -175.29%-2.67B |
| Operating expenses | 20.26%-2.33B | 28.06%-1.56B | 31.87%-790.6M | 29.19%-3.82B | 29.38%-2.93B | 18.79%-2.17B | -2.79%-1.16B | -109.02%-5.4B | -157.56%-4.15B | -175.29%-2.67B |
| Gross profit | -48.61%1.76B | -54.89%1.09B | -47.22%572.95M | -18.06%3.96B | -6.46%3.42B | 2.69%2.43B | 16.62%1.09B | 135.77%4.83B | 178.14%3.65B | 200.90%2.36B |
| Selling expenses | -20.31%-167.22M | -24.86%-102.42M | -31.96%-44.62M | -30.78%-196.42M | -44.38%-138.99M | -59.70%-82.03M | -64.63%-33.82M | -50.86%-150.19M | -50.17%-96.27M | -29.83%-51.37M |
| Administrative expenses | 4.32%-558.27M | -6.78%-374.64M | -3.60%-177.45M | 2.16%-819.58M | -6.76%-583.49M | -0.26%-350.84M | -0.21%-171.29M | -69.31%-837.69M | -75.29%-546.56M | -76.16%-349.95M |
| Research and development expenses | 5.65%-484.14M | -1.61%-328.69M | -4.53%-169.44M | 0.15%-707.86M | -16.04%-513.11M | -22.84%-323.47M | -23.85%-162.1M | -82.95%-708.89M | -71.93%-442.2M | -60.67%-263.32M |
| Impairment and provision | 37.74%-9.93M | 145.30%7.3M | -86.98%1.53M | 61.60%-9.9M | -431.11%-15.94M | 69.48%-16.1M | 238.77%11.73M | -15.23%-25.79M | 61.86%-3M | -746.06%-52.76M |
| -Other impairment is provision | 37.74%-9.93M | 145.30%7.3M | -86.98%1.53M | 61.60%-9.9M | -431.11%-15.94M | 69.48%-16.1M | 238.77%11.73M | -15.23%-25.79M | 61.86%-3M | -746.06%-52.76M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---62.64M | -935.11%-7.78M |
| Special items of operating profit | -21.67%235.55M | -12.02%246.4M | 649.72%112.59M | -42.72%339.35M | -51.11%300.7M | -17.79%280.05M | 40.54%-20.48M | 273.55%592.39M | 437.10%615.04M | 269.58%340.66M |
| Operating profit | -68.70%771.83M | -71.95%542.64M | -58.35%295.55M | -30.72%2.57B | -20.89%2.47B | -2.24%1.93B | 26.97%709.56M | 209.36%3.7B | 304.88%3.12B | 309.78%1.98B |
| Financing cost | -197.66%-3.69M | 9.00%-2.53M | 46.75%-573K | 43.85%-5.91M | ---1.24M | ---2.78M | ---1.08M | ---10.53M | ---- | ---- |
| Share of profits of associates | -137.91%-8.98M | -80.10%-5.46M | -125.93%-315K | -106.56%-2.17M | 390.62%23.7M | -131.71%-3.03M | -85.30%1.22M | 960.73%33.05M | --4.83M | 1,117.57%9.56M |
| Adjustment items of earning before tax | ---- | ---2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -69.49%759.16M | -72.38%532.65M | -58.48%294.66M | -31.35%2.56B | -20.30%2.49B | -3.01%1.93B | 25.15%709.7M | 212.25%3.72B | 303.09%3.12B | 312.57%1.99B |
| Tax | 79.47%-58.98M | 83.68%-40.24M | 81.50%-15.13M | 28.82%-306.31M | 28.30%-287.31M | 0.67%-246.49M | -20.86%-81.81M | -247.89%-430.31M | -403.49%-400.74M | -371.78%-248.16M |
| After-tax profit from continuing operations | -68.19%700.18M | -70.72%492.42M | -55.48%279.53M | -31.68%2.25B | -19.12%2.2B | -3.34%1.68B | 25.73%627.89M | 208.12%3.29B | 291.59%2.72B | 305.31%1.74B |
| Earning after tax | -68.19%700.18M | -70.72%492.42M | -55.48%279.53M | -31.68%2.25B | -19.12%2.2B | -3.34%1.68B | 25.73%627.89M | 208.12%3.29B | 291.59%2.72B | 305.31%1.74B |
| Minority profit | -9.13%-10.15M | -53.44%-6.72M | 0.61%-2.44M | -156.87%-17.99M | ---9.3M | ---4.38M | ---2.46M | -38,811.11%-7M | ---- | ---- |
| Profit attributable to shareholders | -67.86%710.33M | -70.40%499.13M | -55.27%281.97M | -31.28%2.27B | -18.77%2.21B | -3.09%1.69B | 26.22%630.35M | 208.77%3.3B | 291.59%2.72B | 305.31%1.74B |
| Basic earnings per share | -67.05%2.01 | -69.89%1.4 | -55.81%0.76 | -30.60%6.26 | -18.23%6.1 | -2.11%4.65 | 26.47%1.72 | 186.35%9.02 | 159.03%7.46 | 274.02%4.75 |
| Diluted earnings per share | -67.05%2.01 | -69.89%1.4 | -55.81%0.76 | -30.44%6.26 | -17.90%6.1 | -1.90%4.65 | 26.47%1.72 | 187.54%9 | 158.89%7.43 | 276.19%4.74 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data